|
mmu04010
|
MAPK signalling pathway
|
25
|
34
|
3.03E-05
|
6.49E-09
|
|
mmu05412
|
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
|
11
|
9
|
3.60E-04
|
0.011371
|
|
mmu04520
|
Adherens junction
|
11
|
11
|
4.01E-04
|
1.00E-03
|
|
mmu04115
|
p53 signalling pathway
|
10
|
10
|
8.34E-04
|
1.90E-03
|
|
mmu04510
|
Focal adhesion
|
17
|
15
|
0.002282
|
0.032455
|
|
mmu05200
|
Pathways in cancer
|
23
|
21
|
0.003327
|
0.04242
|
|
mmu01100
|
Metabolic pathways
|
83
|
111
|
0.015105
|
0.008450594
|
|
mmu04060
|
Cytokine-cytokine receptor interaction
|
19
|
11
|
0.033202668
|
0.048153254
|
|
mmu04920
|
Adipocytokine signalling pathway
|
7
|
8
|
0.034984
|
0.019396
|
|
mmu05020
|
Prion diseases
|
5
|
6
|
0.037602
|
0.013348
|
|
mmu05416
|
Viral myocarditis
|
8
|
9
|
0.045733
|
0.038737
|
|
mmu04912
|
GnRH signalling pathway
|
11
|
11
|
0.046921
|
0.045341
|
|
mmu04012
|
ErbB signalling pathway
|
7
|
9
|
0.048712
|
0.025918
|
|
Down-Regulated
|
|
mmu00280
|
Valine, leucine and isoleucine degradation
|
8
|
0.004814562
|
6
|
0.049249252
|
|
mmu04114
|
Oocyte meiosis
|
13
|
0.006667
|
12
|
0.03641
|
|
mmu04914
|
Progesterone-mediated oocyte maturation
|
10
|
0.016259
|
10
|
0.031867499
|
|
mmu04930
|
Type II diabetes mellitus
|
7
|
0.024595
|
8
|
0.012683147
|
